These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6442417)

  • 1. Photosensitivity from oral administration of a fluorouracil derivative (FT 207).
    Sun CC; Hsu SC
    Photodermatol; 1984 Apr; 1(2):94-5. PubMed ID: 6442417
    [No Abstract]   [Full Text] [Related]  

  • 2. Photosensitivity due to a fluorouracil derivative.
    Horio T; Murai T; Ikai K
    Arch Dermatol; 1978 Oct; 114(10):1498-500. PubMed ID: 363059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous side-effects caused by Tegafur.
    Revenga F
    Int J Dermatol; 1999 Dec; 38(12):955-7. PubMed ID: 10671104
    [No Abstract]   [Full Text] [Related]  

  • 4. [Invention of a tumor-selective 5-fluorouracil derivative named S-1 by biochemical modulation of 5-fluorouracil].
    Shirasaka T; Shimamoto Y; Kato T; Fukushima M
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):371-84. PubMed ID: 9492831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Photosensitization caused by 5-fluorouracil (5-FU)].
    von Moos R; Sauter C
    Schweiz Med Wochenschr; 1999 Jan; 129(1-2):52. PubMed ID: 10065507
    [No Abstract]   [Full Text] [Related]  

  • 6. Photosensitive lichenoid drug eruption to capecitabine.
    Walker G; Lane N; Parekh P
    J Am Acad Dermatol; 2014 Aug; 71(2):e52-3. PubMed ID: 25037814
    [No Abstract]   [Full Text] [Related]  

  • 7. [Patient preference for oral chemotherapy].
    Schöffski P
    Krankenpfl J; 2002; 40(1-2):40-1. PubMed ID: 12035416
    [No Abstract]   [Full Text] [Related]  

  • 8. Lethal leukoencephalopathy secondary to Tegafur, a 5-fluorouracil prodrug.
    Sierra S; Luquin N; Carrato C
    J Neurol Sci; 2015 Oct; 357(1-2):326-8. PubMed ID: 26242718
    [No Abstract]   [Full Text] [Related]  

  • 9. [Capsule instead of infusion--new oral chemotherapy option].
    Köhne CH
    Krankenpfl J; 2002; 40(1-2):42-3. PubMed ID: 12035417
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor drug.
    Hirata K; Horikoshi N; Aiba K; Okazaki M; Denno R; Sasaki K; Nakano Y; Ishizuka H; Yamada Y; Uno S; Taguchi T; Shirasaka T
    Clin Cancer Res; 1999 Aug; 5(8):2000-5. PubMed ID: 10473078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tegaful photosensitivity--lichenoid and eczematous types.
    Horio T; Yokoyama M
    Photodermatol; 1986 Jun; 3(3):192-3. PubMed ID: 3092199
    [No Abstract]   [Full Text] [Related]  

  • 12. Capecitabine and tegafur + uracil: new preparations. Metastatic colorectal cancer: two oral fluorouracil precursors, few advantages.
    Prescrire Int; 2002 Apr; 11(58):44-7. PubMed ID: 11987311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible regulation of 5-fluorouracil-induced neuro- and oral toxicities by two biochemical modulators consisting of S-1, a new oral formulation of 5-fluorouracil.
    Kato T; Shimamoto Y; Uchida J; Ohshimo H; Abe M; Shirasaka T; Fukushima M
    Anticancer Res; 2001; 21(3B):1705-12. PubMed ID: 11497250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical survey on cardiotoxicity of tegafur (FT-207)--compilation of a nationwide survey].
    Kikuchi K; Majima S; Murakami M
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1482-8. PubMed ID: 6820919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised study of tegafur and oral leucovorin versus intravenous 5-fluorouracil and leucovorin in patients with advanced colorectal cancer.
    Nogué M; Salud A; Batiste-Alentorn E; Saigí E; Losa F; Cirera L; Méndez M; Campos JM; Galan A; Escudero P; Arcusa A; Manzano H; de Mendizábal EV; de Olaguer JP; Boleda M; Guasch I; Vicente P
    Eur J Cancer; 2005 Oct; 41(15):2241-9. PubMed ID: 16214045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug exanthema caused by a new 5-fluorouracil derivative].
    Ueki H; Namba M
    Hautarzt; 1980 Apr; 31(4):207-8. PubMed ID: 6772600
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
    Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
    Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protracted treatment with tegafur and low dose oral leucovorin in patients with advanced colorectal carcinoma.
    Nogué M; Seguí MA; Saigí E; Batiste-Alentorn E; Arcusa A; Boleda M; Antón I
    Cancer; 1998 Jul; 83(2):254-8. PubMed ID: 9669807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photosensitivity associated with fluorouracil, prochlorperazine, and topical tretinoin.
    Birner AM; Meyer LP
    Pharmacotherapy; 2001 Feb; 21(2):258-60. PubMed ID: 11213863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of FT-207 on bladder cancer in rats induced by BBN. II: The effect of oral administration of FT-207 during oncogenesis of bladder cancer].
    Okajima E; Hiramatsu T; Kihoin K; Ijuin M; Hirao Y; Ohara S; Babaya K; Tanaka M; Maruyama Y
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):473-9. PubMed ID: 6820898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.